United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - acetazolamide - powder for solution for injection - 500mg

Malta - English - Medicines Authority

mercury pharmaceuticals limited capital house, 85 king william street, london ec4n 7bl, united kingdom - acetazolamide - powder for solution for injection - acetazolamide 500 mg - ophthalmologicals

Ireland - English - HPRA (Health Products Regulatory Authority)

amdipharm limited - acetazolamide - tablet - 250 milligram(s) - carbonic anhydrase inhibitors; acetazolamide

Ireland - English - HPRA (Health Products Regulatory Authority)

amdipharm limited - acetazolamide sodium - powder for solution for injection - 500 milligram/vial - carbonic anhydrase inhibitors; acetazolamide

Australia - English - Department of Health (Therapeutic Goods Administration)

acetazolamide -

Australia - English - Department of Health (Therapeutic Goods Administration)

acetazolamide -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.24 mg/g (equivalent: betamethasone, qty 0.2 mg/g) - cream - excipient ingredients: cetomacrogol 1000; cetostearyl alcohol; white soft paraffin; liquid paraffin; purified water; chlorocresol; monobasic sodium phosphate; phosphoric acid; sodium hydroxide - indications as at 23 april 2004 : eczema includiing: atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sanwa kagaku kenkyusho co.,ltd. - acetazolamide - white tablet, with a split line, φ11.1mm, thickness 4.6mm

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zulat pharmacy sdn. bhd. - acetazolamide -

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - sodium valproate 199.8mg; valproic acid 87mg (as navalproate 100.3mg) - modified release tablet - 300 mg - active: sodium valproate 199.8mg valproic acid 87mg (as navalproate 100.3mg) excipient: erythrosine ethylcellulose hydrated silica hypromellose   indigo carmine iron oxide black propylene glycol purified water titanium dioxide - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy.